| http://www.w3.org/ns/prov#value | - Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.Full TextThe Full Text of this article is available as a PDF (106K).Selected ReferencesThese references
|
